Fei Zhou

机构：Shanghai East Hospital · ORCID：0000-0002-5865-0052

发表论文 163 篇 · 总被引 5862 次 · h-index 39

代表论文

• The changing treatment landscape of EGFR-mutant non-small-cell lung cancer (2024 · Nature Reviews Clinical Oncology · 被引 159)
• Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches (2025 · Nature Reviews Clinical Oncology · 被引 36)
• In Situ , Fusion-Free, Multiplexed Detection of Small Extracellular Vesicle miRNAs for Cancer Diagnostics (2024 · Analytical Chemistry · 被引 21)
• Minor (≤ 10%) Ground-Glass Opacity Component in Clinical Stage I Non–Small Cell Lung Cancer: Associations With Pathologic Characteristics and Clinical Outcomes (2024 · American Journal of Roentgenology · 被引 15)
• Polyene phosphatidylcholine enhances the therapeutic response of oxaliplatin in gastric cancer through Nrf2/HMOX1 mediated ferroptosis (2024 · Translational Oncology · 被引 11)
• First-in-human, phase 1 dose-escalation and dose-expansion study of a RET inhibitor SY-5007 in patients with advanced RET-altered solid tumors (2024 · Signal Transduction and Targeted Therapy · 被引 10)